Marty Jablow DMD, Dental News and Technology

quip Announces Supplier Package Agreement with Henry Schein for Availability of the Ultra Next-Generation Smart Sonic Toothbrush to Dental Professionals Nationwide

2026-05-08T15:19:00.003-04:00

Supplier package agreement makes quip’s newest rechargeable electric toothbrush available through the Henry Schein platform

quip, the modern oral care brand known for making good oral health habits more simple, accessible, and enjoyable, recently announced a new supplier package agreement with Henry Schein, one of the world’s leading providers of healthcare products and solutions to office-based dental and medical practitioners.

Dental professionals can now purchase the quip Ultra™ Smart Sonic Rechargeable Electric Toothbrush (the “quip Ultra”) through Henry Schein, offering a patient-friendly solution that supports compliance, in-office retail, new patient welcome kits, and patient recommendation programs — all with access to quip’s wholesale pricing structure that delivers over 30% savings compared to retail. The agreement marks an important step in making quip available through Henry Schein and expanding access to the brand’s newest technology for dental professionals.

Clinically, the quip Ultra delivers 15x more plaque removal between teeth¹ and 2x more whitening within one week², both versus a regular manual toothbrush—performance that gives dental professionals a confident, evidence-based recommendation to make chairside. Dental professionals purchasing through Henry Schein also receive an additional brush head and a coupon card with each unit, providing a bundled value for practices that incorporate quip into patient care programs.

“We’re pleased to make quip Ultra available through a trusted purchasing platform used by dental professionals nationwide,” said Ronnie Delphin, Manager, Sales Operations at quip. “Henry Schein’s reach and reputation within the dental community gives us the ideal platform to put our newest technology directly into the hands of the clinicians who recommend these products every day. This is just the beginning of what we expect to be a long and productive relationship.”

“Our customers are increasingly looking for solutions that bridge clinical efficacy with patient engagement,” said Meredith Glansberg, CEO of quip. “quip Ultra brings a modern, connected approach to home care that aligns with how today’s practices are educating and motivating patients.”

The quip Ultra features Bluetooth connectivity with the quip app, 10+ brushing modes, a wireless charger, and a travel case. Its EasyClick Brush Pod features soft replaceable bristles and produces 70% less waste than traditional brush heads.³ A single charge lasts up to 30 days, and a guiding pressure sensor with LED light pulses alerts users to brush more gently and prevent harsh brushing — making it one of the most thoughtfully engineered offerings in quip’s lineup. The quip Ultra also earned a 2025 TIME Best Inventions Award in the Design Category, recognized for its sleek design, intuitive technology, and accessible price point that bring professional-level oral care into everyday routines.⁴

The Henry Schein supplier package agreement expands access to quip’s broader offering, centered around quippros.com, the brand’s B2B platform where dental offices can sign up, order wholesale products, and access professional resources including continuing education, an ambassador program, and monthly communications reaching more than 86,000 dental professionals and students.

Dental professionals interested in learning more about the quip Ultra and its availability through Henry Schein can visit https://www.henryschein.com/en-us/p/quip-ultra-next-generation-sonic-rechargeable-electric-toothbrush-white-ea/1490806 or stop by the quip booth #1275 at the California Dental Association Annual Meeting, May 14–16, 2026, at the Anaheim Convention Center in Anaheim, California.

REFERENCES

1 & 2: data on file, quip, 2026.

3. Versus quip Sonic Toothbrush refill, by weight.

4. https://www.prnewswire.com/news-releases/quip-ultra-smart-sonic-toothbrush-wins-times-best-inventions-of-2025-award-302643968.html

About quip

Since its inception in 2015, quip has been on a mission to improve oral health by turning a “have to” chore into a “want to” ritual. With a commitment to simple, science-backed design, quip creates intuitive, effective products that make oral health accessible to all. In addition to its highly acclaimed electric toothbrushes, quip offers a full range of personal care products, including water flossers, toothpaste, refillable floss string, and mints. With more than 54 million products sold and millions of subscribers nationwide, quip is available at Target, Walmart, CVS, and other retailers throughout the US. Learn more at www.getquip.com.

About Henry Schein

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for healthcare professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government, and institutional health care clinics, as well as other alternate care sites.

VISALYS Bulk Fill Delivers Esthetic Restoration

2026-05-07T15:19:00.005-04:00

Perfectly complemented: Kettenbach Dental’s composite line continues to grow
The new restorative composite VISALYS® Bulk Fill – for durable restorations within a system

With VISALYS Bulk Fill, Kettenbach Dental introduces a packable bulk-fill composite that meaningfully expands its existing product line. Developed for posterior restorations, the material combines efficient single-layer application with inherent material stability, addressing key requirements in everyday clinical practice.

With the introduction of VISALYS Bulk Fill, Kettenbach Dental continues to consistently expand its modular bulk system. In combination with the flowable VISALYS Bulk Flow, users benefit from a coordinated system that provides a suitable solution for both cavity bases and definitive restorations. This enables flexible implementation of individual treatment concepts—for efficient workflows and reliable results in daily practice.

Stable margins through low water absorption

A key feature of VISALYS Bulk Fill is its very low water absorption of just 9.8 µg/mm³. This property makes a significant contribution to the long-term stability of restorations, as it reduces the risk of marginal changes and supports the integrity of the filling over time. Combined with high abrasion resistance, this creates a reliable foundation for durable posterior restorations.

Efficient handling

VISALYS Bulk Fill allows for quick and reliable single-layer application up to 4 mm. This reduces treatment steps and allows for more efficient workflows. The low polymerization shrinkage stress supports stress-free curing, while the excellent sculptability enables precise adaptation to the cavity. These features facilitate both direct application in practice and the implementation of advanced restorative concepts.

Esthetics and versatility

The one-shade concept ensures harmonious integration into the natural tooth structure, enabling esthetically convincing results without complex shade selection. At the same time, the material offers a broad range of indications—from Class I to Class V restorations, pediatric fillings, and core build-ups.

With VISALYS Bulk Fill, Kettenbach Dental expands its portfolio with a high-performance bulk-fill composite that stands out for its material stability, handling efficiency, and esthetic capabilities. The one-shade system allows users to experience just how esthetic a bulk composite can be.

For more information about the product, please visit www.kettenbach-dental.us.

About Kettenbach LP

Kettenbach LP is located in Huntington Beach, CA, and is the exclusive U.S. distributor for Kettenbach GmbH & Co. KG located in Eschenburg, Germany. Founded by August Kettenbach in 1944, Kettenbach GmbH was created for the development and marketing of medical and dental products. Today, the company is one of the leading international producers of dental impression materials and resin restorative materials, and now preventive materials.

AAE Study Highlights Impact of Research Collaboration

2026-05-06T13:01:00.001-04:00

The American Association of Endodontists (AAE) is recognizing the publication of a new peer-reviewed study examining the impact of a longstanding collaboration between the AAE and the National Dental Practice-Based Research Network (National Dental PBRN). The article, published in the Journal of the American Dental Association(JADA), underscores how large-scale, practice-based research partnerships are driving meaningful advancements in endodontic care.

The study, led by Dr. Veerasathpurush Allareddy, Dr. Alan S. Law, Dr. Joana Cunha-Cruz, and Dr. Gregg H. Gilbert on behalf of the National Dental Practice-Based Research Network Collaborative Group, evaluates more than a decade of collaborative research. Findings show that resulting publications have had a measurable and significant influence on the field, with articles cited 72% more often than typical NIH-funded research—an indicator of strong clinical relevance and impact.

Through this collaboration, endodontic studies conducted in real-world clinical settings have led to insights that directly inform patient care—ranging from improved pain management strategies to enhanced diagnostic protocols and treatment planning tools.

“This publication reinforces the power of collaboration in advancing our specialty,” said AAE President Dr. W. Craig Noblett. “By working alongside the National Dental Practice-Based Research Network, our members are helping generate high-quality, practice-based evidence that improves patient outcomes and strengthens the foundation of endodontic care.”

Over multiple funding cycles, this collaboration has supported numerous studies and produced a growing body of literature that bridges the gap between research and everyday clinical practice. At the heart of this success are the AAE members who stepped forward—often balancing busy practices—to participate in studies, contribute data, and help translate research into real-world impact.

The AAE extends its deepest gratitude to these members. Their willingness to engage, collaborate, and lead within a practice-based research model is not just appreciated—it is essential. Their contributions have directly advanced the specialty, strengthened the evidence base for endodontic care, and ultimately improved outcomes for patients across the country. This work reflects the very best of the profession: a shared commitment to continuous learning, clinical excellence, and advancing care for the benefit of all.

The AAE also recognizes and thanks the study authors for their leadership and contributions to advancing endodontic science.

For more information about AAE’s ongoing commitment to research and clinical excellence, visit www.aae.org.

TheraBreath Partners With Demi Lovato for Freshness

2026-05-05T13:02:00.001-04:00

TheraBreath and Demi bring freshness to the forefront of get-ready routines; plus, a chance to win tickets and a trip to a concert stop on Demi’s It’s Not That Deep Tour

TheraBreath, the revolutionary dentist-formulated oral care brand, has partnered with longtime fan and global superstar Demi Lovato to empower fans to show up as their freshest selves so they, too, can own every moment. The brand’s new mantra—Ready. Fresh. Go.—is rooted in the insight that feeling unstoppable starts with long-lasting fresh breath. TheraBreath delivers freshness through its best-selling oral rinses and expanding line of toothpastes, proving that even simple “get-ready” rituals like oral care can help people show up as their best selves.

As a longtime fan of the brand, with TheraBreath products being part of her get-ready routine on her current It’s Not That Deep Tour and beyond, Demi Lovato brings the “Ready. Fresh. Go.” mindset to life, spotlighting the role freshness plays in her daily routine—from stepping on stage to everyday moments.

“Feeling fresh helps me show up as my best self, whether I’m on stage performing in arenas or just spending time with the people I love,” said Lovato. “That’s what TheraBreath represents to me—it’s that small but impactful step in my routine that helps me walk into any moment feeling my absolute best to ‘Ready. Fresh. Go.'”

As Demi kicks off her It’s Not That Deep Tour with TheraBreath as an essential part of her prep, the brand is giving fans the chance to win an exclusive concert experience by entering the “Ready. Fresh. Go… See Demi Lovato with TheraBreath” Sweepstakes. From now through May 3, fans can enter for a chance to win:

Two tickets to Demi Lovato’s It’s Not That Deep Tour stop in Austin, Texas (May 24)
Round-trip, three-night travel (including flight, hotel, and stipend) to Austin
TheraBreath oral care products and exclusive merch

How to enter:

Follow @TheraBreath on Instagram
Tag a friend on the @TheraBreath official sweepstakes post to secure one (1) entry
Share the designated post to Instagram Stories along with #TheraBreathSweepstakes for one (1) additional bonus entry

An authentic user of TheraBreath products, Demi has partnered with the brand to bring long-lasting freshness to fans, both on and off the stage, through a multifaceted campaign that includes social content, a digital and video campaign, cookbook launch activations, concert sweepstakes giveaways, and concert sampling.

TheraBreath oral rinses and toothpastes are designed to fight bad breath, support oral hygiene, and deliver fresh breath without alcohol, giving consumers that just-brushed fresh feeling that lasts so they’re always ready before the moment hits. From its TikTok-viral oral rinses to its newly launched line of toothpastes, TheraBreath oral care products are designed to be mixed and matched to deliver superior flavor and a premium, sensorial experience, making fans feel unstoppable to Ready. Fresh. Go.

For more information about TheraBreath and its products, visit www.TheraBreath.com, and follow the brand (@TheraBreath) on TikTok and Instagram for ongoing product news.

NO PURCHASE NECESSARY TO ENTER OR WIN IN THE THERABREATH “Ready. Fresh. Go… See Demi Lovato with TheraBreath” SWEEPSTAKES. Open to legal residents of the contiguous 48 U.S. and D.C. who are 18 or older and the age of majority in their state of legal residence. Void in AK, HI, and where prohibited. Sweepstakes starts 4/20/26 at 9:00 AM ET and ends 5/3/26 at 11:59 PM ET. For Official Rules, which govern, click here. Sponsor: Church & Dwight Co., Inc.

About TheraBreath

In 2021, the TheraBreath brand was acquired by Church & Dwight Co., Inc., becoming the latest addition to its family of oral care products, which include Waterpik® water flossers, ARM & HAMMER™ toothpaste, and Spinbrush™ toothbrushes. TheraBreath founder Dr. Harold Katz created the oral care rinses at the California Breath Clinics over 30 years ago. TheraBreath products are revolutionary because they attack the germs that cause bad breath. TheraBreath has grown to have an extensive line of oral care products that address issues such as gum health, teeth whitening, cavity prevention, and dry mouth symptoms.

About Demi Lovato

Demi Lovato is a GRAMMY-nominated and award-winning musician, actor, and two-time New York Times best-selling author. She was first known for her onscreen talents and soon after became a global musical phenomenon for her remarkable vocal ability. With over 50 billion streams earned worldwide, Demi has released nine original studio albums, all of which debuted in the Top 10 of the Billboard 200, and four of which boast over one billion streams on Spotify. Most recently, she released her critically acclaimed album It’s Not That Deep and is currently supporting the album on her arena-headlining It’s Not That Deep Tour. With an audience of over 290 million on social media, Demi has established herself as a global sensation.

ADHA to Host Inaugural Integrated Care Summit

2026-05-04T08:38:00.004-04:00

Two-day event in Broomfield, Colorado, brings dental, medical and behavioral health professionals together for hands-on collaboration

The American Dental Hygienists’ Association (ADHA) recently announced the Integrated Care Summit 2026: Bridging the Gaps to Whole-Person Care, a two-day interprofessional symposium and workshop in Broomfield, Colorado. The event brings dental hygienists, dentists, physicians, nurses, pharmacists, behavioral health professionals and public health leaders together to address the gaps between oral, medical and behavioral health care.

The summit takes place May 15–17 at the Omni Interlocken Resort and offers 10.0 live/interactive CE and CME credits. CareQuest Institute for Oral Health and Henry Schein are anchoring the event as platinum sponsors, with additional support from industry and nonprofit partners.

Nearly 42% of U.S. adults 30 and older have periodontal disease, according to CDC data. In December 2025, the American Heart Association published an updated scientific statement in Circulation detailing growing evidence that links periodontal disease to increased risk of heart attack, stroke, atrial fibrillation and heart failure—and recommending that high-risk cardiovascular patients receive regular dental screenings. Yet most medical training programs dedicate fewer than five hours to oral health education.

The American Heart Association’s Healthy Smiles, Healthy Hearts Initiative and the Academy of General Dentistry joining as collaborating organizations, bringing medical and dental leadership to the summit, signals that the demand for integrated care spans well beyond oral care.

“Interprofessional collaboration only matters if it happens in practice. Having the American Heart Association and the Academy of General Dentistry participating on this summit with ADHA shows that the commitment to coordinated care is there across disciplines. Now we put it to work,” said Lancette VanGuilder, BS, RDH, ADHA president.

Attendees will work through interprofessional care mapping exercises, clinical simulation labs and breakout sessions on biomarkers, tele-dentistry, behavioral health integration and health equity. On the exhibit floor, an Activation Station Lounge lets attendees analyze their saliva and receive an Oral Fitness Score in minutes using Dento’s ORALyzer technology, run blood pressure screening simulations with the American Heart Association’s Healthy Smiles, Healthy Hearts Initiative and practice A1C point-of-care testing at the Henry Schein station.

“We have long advocated for a more holistic, systemic approach to healthcare—one that prioritizes prevention and wellness across medical, dental, and mental health—because it delivers a win-win-win: healthier patients, stronger families, and lower costs for society,” said Pam Richter, Director, Corporate Affairs at Henry Schein. “With growing evidence linking oral health to systemic conditions, dental hygienists are uniquely positioned to advance integrated care by leading prevention, identifying early risk, and bridging oral and overall health. Events like the ADHA’s Integrated Care Summit serve as an important platform for advancing collaboration, creating awareness, and accelerating the adoption of an improved form of integrated care.”

Between sessions, attendees can join morning fitness classes, guided mindfulness and wellness-focused networking breaks, reinforcing the summit’s focus on whole-person health across the full event experience.

“Addressing complex challenges like integrated care requires intense collaboration from across the health care ecosystem,” said Katie D’Amico, Vice President of Growth & Innovation at CareQuest. “We are proud to support the ADHA as a convenor for the important conversations that turn insights into action and ultimately deliver better patient outcomes.”

The event is dual accredited for dental professionals through the American Academy of Dental Hygiene and for medical professionals through the ACCME, ACPE and ANCC, with joint accreditation provided by ADCES.

Registration is open at adha.org/ICS26.

About the American Dental Hygienists’ Association

The American Dental Hygienists’ Association (ADHA) is the largest organization representing the professional interests of the more than 220,000 dental hygienists in the United States. Dental hygienists are preventive oral health professionals, licensed in dental hygiene, who provide educational, clinical and therapeutic services that support total health through the promotion of optimal oral health. The Journal of Dental Hygiene (JDH), published bimonthly, is ADHA’s peer-reviewed scientific journal and flagship publication. To learn more about the ADHA, dental hygiene or the link between oral health and general health, visit adha.org.

ADA and ADEX Advance Dental Licensure Examinations Through New Agreement

2026-05-01T12:21:00.005-04:00

ADEX to incorporate the Dental Licensure Objective Structured Clinical Examination (DLOSCE) into the ADEX Dental Examination no later than Aug. 1, 2026

The American Dental Association (ADA) and the American Board of Dental Examiners (ADEX) have finalized an agreement to license the ADA’s Dental Licensure Objective Structured Clinical Examination (DLOSCE) for incorporation into the ADEX Dental Examination, marking a significant step forward in modernizing dental licensure and advancing patient safety.

The agreement benefits public health, dental licensure candidates, the dental profession, and licensing boards by helping ensure dentists enter the profession with proven competence and uphold the highest standards for patient safety.

The integration of the ADA’s DLOSCE simplifies licensure pathways and supports licensure portability, benefiting candidates seeking to practice in 48 states and other jurisdictions—including Washington, D.C., Puerto Rico, Jamaica, and the U.S. Virgin Islands—that currently accept or require the ADEX Dental Examination.

“This agreement represents an important milestone for the dental profession,” said Dr. Richard Rosato, DMD, president of the ADA. “By aligning pathways to licensure and advancing candidate assessment, we are strengthening licensure portability, supporting a more mobile and responsive workforce, and ensuring that patient safety remains paramount. The ADA has long championed solutions that modernize licensure while protecting the public, and this collaboration reflects our commitment to shaping a strong, sustainable future for dentistry in service to public health.”

The ADEX Dental Examination, with its DLOSCE component, represents a modernized, evidence-based approach to evaluating clinical competence and readiness for practice. The ADEX Dental Examination will continue to assess candidates’ clinical hand skills alongside their treatment planning and decision-making abilities. Through inclusion of the DLOSCE, the ADEX Dental Examination will benefit from the DLOSCE’s extensive use of images and 3D models that allow candidates to demonstrate their clinical judgment in scenarios that closely mirror real-world practice.

“ADEX has long served state dental boards to support licensure processes that reflect both public protection and clinical competence,” said Dr. Mark Armstrong, Chair of ADEX. “This agreement continues that work by strengthening alignment across assessment components while preserving the clinical hand-skills evaluation that remains central to licensure in most U.S. jurisdictions.”

The agreement follows extensive collaboration among the ADA, ADEX, the Joint Commission on National Dental Examinations (JCNDE), and the ADA Council on Dental Education and Licensure (CDEL) that began in 2025. In March 2026, the ADA Board of Trustees and ADEX Board of Directors voted to approve the general terms that led to this joint agreement.

Central to discussions was a shared commitment to ensuring that dental licensure assessments continue to evolve in step with advancements in clinical education, technology, and patient care. Both organizations emphasized the importance of strengthening public protection while also enhancing the portability of dental licensure for candidates navigating an increasingly mobile profession.

ADEX will sunset its DSE OSCE no later than Aug. 1, 2026. Upon sunset of the DSE OSCE, all ADEX Dental Examination administrations will include the DLOSCE.

The DLOSCE will no longer be offered or administered as a standalone examination to new DLOSCE candidates, except in conjunction with the ADEX Dental Examination, after Aug. 1, 2026. All standalone administrations of the DLOSCE will cease after Oct. 9, 2026.

About the American Dental Association

The not-for-profit ADA is the nation’s largest dental association, representing more 152,000 dentist members. The premier source of oral health information, the ADA has advocated for the public’s health and promoted the art and science of dentistry since 1859. The ADA’s state-of-the-art research facilities develop and test dental products and materials that have advanced the practice of dentistry and made the patient experience more positive. The ADA Seal of Acceptance has long been a valuable and respected guide to consumer dental care products. The Journal of the American Dental Association (JADA), published monthly, is the ADA’s flagship publication and the best-read scientific journal in dentistry.

For more information about the ADA, visit ADA.org.

For more information on oral health, including prevention, care and treatment of dental disease, visit the ADA’s consumer website MouthHealthy.org.

About the American Board of Dental Examiners

The American Board of Dental Examiners (ADEX) is a not-for-profit organization dedicated to supporting dental boards in their mission to protect the public through the licensure of qualified oral health professionals. Established in 1969, ADEX administers independent competency examinations developed and approved by representatives of state dental boards. ADEX examinations are accepted or required by law in 51 U.S. jurisdictions and serve as the initial licensure pathway for 98% of dental and 85% of dental hygiene candidates nationwide. Through ongoing collaboration with dental boards and educators, ADEX continues to advance innovative, evidence-based assessment methods that uphold the highest standards of fairness, clinical competence, and public protection.

Learn more at adextesting.org.

Spear Education Expands Training and Programs for 2026

2026-04-30T14:37:00.006-04:00

Spear Education, the leading provider of advanced dental training and dental workforce enablement solutions, is building on strong momentum in 2026, with growth driven by Spear Summit results, expanded partnerships, and new programming.

This year’s summit drew a global community of clinicians and provided dedicated time to connect and network. Internationally recognized dentists from Brazil, Germany, and Italy led seminars and discussions. Attendees were also inspired by Dr. Frank Spear’s session titled “What Are You Going to Do with the Rest of Your Life?” along with the broader curriculum focused on clinical excellence, decision-making, and practice growth. Spear Summit once again attracted a highly engaged audience, with 94% of attendees reporting a positive overall experience.

“We are seeing a strong response from dentists who are looking for clarity in how they grow and how they can effectively manage and retain their teams,” said Matthew Coggin, chief executive officer of Spear Education. “Summit is where those conversations happen in a meaningful way. We want to partner with them to reach their ideal practice and support them with clinical learning, but also support in the form of leadership training, team learning pathways, and coaching so they can build the practice and business they want.”

In addition to the positive response to this year’s Spear Summit, Spear Education has been focused on expanding its partner relationships and product growth. In Q1 of this year, the company deepened its work with Overjet and Align Technology, further supporting clinicians with integrated tools and education that connect clinical care with emerging technologies.

Alongside these partnerships, Spear has introduced several new and expanded learning experiences, in addition to releasing a reimagined learning platform in early Q1. Spear Online has been updated to offer a new online learning experience that provides personalized learning pathways, improved navigation, and expanded course content for dentists at every stage of their careers.

Additionally, Spear released a Hygiene Mastery Program and live webinar series. The program is an always-on resource for dentists who want to develop their hygienists as co-therapists driving diagnoses and growth from the hygiene chair. Dentists can ensure consistent patient care by using this program to onboard and train their hygiene teams on an ongoing basis, ensuring that every new team member shares the same framework for high-quality patient care.

“Our focus is on giving dentists and their teams practical ways to improve both clinical outcomes and the business side of their practice,” said Dr. Dan Butterman, chief dental officer at Spear Education. “That includes everything from restorative planning to financial decision-making. The goal is to meet clinicians where they are and give them a clear path forward.”

Spear Education is continuing its in-person programming throughout 2026, including regional seminars led by Dr. Gregg Kinzer in Dallas; Nashville, Tenn.; and Atlanta. He will present Private Practice Realities: How to Enhance Your Clinical Outcomes, a deep dive into how high-performing dentists improve patient care and practice growth. The company will also host Ortho-Restorative Integration: From Planning to Practice across multiple dates in Scottsdale, Ariz., and Raleigh, N.C., along with the Women in Dentistry Retreatscheduled for October 16–17 in Scottsdale.

The next Spear Summit will take place April 7–10, 2027, at the JW Marriott Grande Lakes in Orlando, Fla.

Dentists can explore Spear Education’s platform and create a free Discover account at https://account.speareducation.com/register.

About Spear Education

Spear Education is the leading provider of advanced dental training and dental workforce enablement solutions, equipping dentists and their teams with the clinical and leadership capabilities needed to enhance patient care and grow their practices. Through a blend of tech-enabled virtual learning, hands-on workshops, live seminars, and study clubs, the company is committed to advancing modern dentistry at every level. For more information, visit www.speareducation.com.

GoTu's 2026 State of Work Report Shows Dental Workforce at a Critical Inflection Point

2026-04-30T08:38:00.000-04:00

Developed with ADHA, the nation's largest dental workforce study uncovers
sustained burnout, limited compensation growth, and increasing mobility

MIAMI, April 29, 2026 /PRNewswire/ -- GoTu Technology, the nation's leading dental talent marketplace, today released its annual State of Work Report, the largest ongoing study of the U.S. dental workforce. The 2026 study reflects responses from nearly 8,000 dental hygienists, dental assistants, and associate dentists across all 50 states, offering the industry's most comprehensive view into how dental professionals are working and why many are reconsidering where and how they stay in the field.

Developed in partnership with the American Dental Hygienists' Association (ADHA), the findings reflect the full breadth of the profession, from single provider practices to multilocation groups nationwide. Now in its third year, the dataset reveals a profession deeply committed to patient care, with 82.8 percent planning to stay in dentistry for at least the next decade. However, the conditions inside practices continue to erode that commitment at the local level.

Key findings include:

A workforce under sustained pressure. Compensation has not improved for the third straight year, with 59 percent receiving no raise, 74.7 percent receiving no bonus, and 44.7 percent lacking benefits.
Burnout remains high, affecting 54.1 percent of all dental professionals and 60.6 percent of hygienists, driven largely by workload and office culture.
Retention challenges continue, with 64 percent reporting their longest tenure at any practice is five years or less and office switching rising again this year.

"These findings show a workforce that is not walking away from dentistry – it is adapting to survive in it," said Edward Thomas, co-founder and co-CEO of GoTu. "The data is clear: when compensation, culture and autonomy do not improve, people adjust their behavior. Practices that respond to these signals now will be the ones that retain talent in the years ahead."

The report also highlights a shift in how dental professionals manage their careers. Temporary work has become a deliberate strategy for flexibility and income stability rather than a fallback. Many professionals are disengaging instead of resigning outright, a subtle yet significant indicator of workplace strain.

"This report confirms what hygienists have been telling us; stalled compensation, high burnout, and limited clinical autonomy are undermining retention across the profession," said ADHA President Lancette VanGuilder, BS, RDH. "This data supports initiatives we're driving to strengthen the workforce and keep experienced hygienists in practice."

"Our goal is to give the industry a clear, unfiltered view of what dental professionals are experiencing," said Cary Gahm, co-founder and co-CEO of GoTu. "Nearly 8,000 voices are telling us the same story. They want workplaces that make staying sustainable. When we listen to them, the entire profession becomes stronger."

The report's six focus areas — workforce demographics, compensation, burnout and well-being, temporary work, clinical autonomy, and industry challenges — give industry leaders a clear, data-driven view of the conditions shaping today's dental workforce.

To download the full report, please visit https://sow.gotu.com/.

About GoTu

GoTu (formerly TempMee) is a pioneering, technology-driven workforce solution and skill-sharing marketplace serving the dental industry. The platform allows dental offices to contract directly with registered dental hygienists, dental assistants, and associate dentists to fill both short-term and permanent positions. Launched in 2019, GoTu has filled more than 500,000 shifts nationwide, empowering dental professionals with flexibility and control while ensuring practices can deliver exceptional patient care. Miami-based GoTu has grown from a bootstrapped startup to an institutional investor-backed powerhouse with 120+ team members. For more information, visit www.gotu.com.

About the American Dental Hygienists' Association

The American Dental Hygienists' Association (ADHA) is the only organization representing the professional interests of the more than 220,000 dental hygienists in the United States. Dental hygienists are preventive oral health professionals, licensed in dental hygiene, who provide educational, clinical and therapeutic services that support total health through the promotion of optimal oral health. To learn more about the ADHA, dental hygiene or the link between oral health and general health, visit www.adha.org.

SOURCE GoTu

FXClear Study Shows Faster Aligner Results

2026-04-29T13:57:00.006-04:00

Preliminary Findings From a Retrospective Comparison Study Highlight Effectiveness and Clinical Advantages of the FXClear Proprietary Aligner System.

OrthoFX More Predictable Clinical Outcomes – Comparison

OrthoFX, a leader in innovative clear aligner technology, recently announced preliminary results from a retrospective clinical study comparing the treatment effectiveness and predictability of its FXClear aligner system with the leading clear aligner brand, Invisalign. The study, titled “Treatment Effectiveness of FXClear Aligner: A Comparison Clinical Study,” demonstrates that FXClear achieved significantly shorter treatment duration, fewer total visits, fewer aligners used, and more precise planned-to-final geometric fidelity than Invisalign, while maintaining comparable finishing quality in mild-to-moderate malocclusion cases.

Key Efficiency Findings

The retrospective analysis represents the first head-to-head comparison of comprehensive treatment effectiveness parameters between two clear aligner systems in a clinical setting. The study was conducted across three private orthodontic practices and evaluated 111 cases (54 FXClear cases and 57 Invisalign cases) with comparable baseline malocclusion severity (American Board of Orthodontics Discrepancy Index (DI) scores of 13.20 vs. 14.70; p=.056). Both groups were treated by the same orthodontist using identical 7-day aligner change protocols. The preliminary study revealed:

Treatment Duration: FXClear cases completed treatment in an average of 17.3 months compared to 23.0 months for Invisalign—a reduction of nearly six months, or 25% (p=.005).
Fewer Aligners: FXClear cases required an average of 49 aligners versus 82 for Invisalign—a 40% reduction (p<.001).
Fewer Total Visits: FXClear cases averaged 12.6 visits compared to 15.4 for Invisalign (p=.001), driven by significantly fewer virtual monitoring visits (2.3 vs. 5.5; p<.001). In-office visits remained comparable (p=.533), indicating that efficiency gains stemmed from optimized treatment protocols rather than reduced clinical oversight.

Geometric/Morphometric Comparison

Greater Treatment Precision: 3D superimposition analysis of planned vs. actual treatment outcomes showed FXClear (n=14) achieved significantly lower deviation (RMS) in both the upper arch (p=.0005) and lower arch (p=.0001), with 39–43% of surface points falling within ±0.5 mm tolerance compared to 27–28% for Invisalign (n=14).
Comparable Finishing Quality: Modified ABO Objective Grading System scores confirmed that both systems achieved comparable clinical outcomes (n=10 for each group).

Clinical Significance

One of the most clinically significant findings involved treatment predictability. Digital superimposition revealed that Invisalign cases exhibited deviations of up to 1.0 mm in mandibular posterior occlusal surfaces, suggesting possible unwanted posterior open bite—a commonly reported complication. FXClear showed deviations of less than 0.5 mm in comparable areas, indicating more consistent planned-to-final geometric fidelity.

“These findings suggest that FXClear may offer potential efficiency advantages in clear aligner therapy,” the study authors concluded. “In mild-to-moderate complex cases, the FXClear aligner system resulted in fewer total visits, shorter treatment duration, and fewer aligners used compared to the Invisalign aligner system.”

Clinical Implications

For orthodontists, the results highlight a meaningful clinical alternative in the clear aligner market. With 40% fewer aligners per case and nearly six fewer months of treatment time, FXClear offers improved practice efficiency and streamlined scheduling without compromising quality.

For patients, the data points to a shorter treatment journey, fewer appointments, and greater predictability.

Company Commentary

“These preliminary results validate what our clinical partners have been telling us—FXClear delivers a meaningfully different experience for both the orthodontist and the patient,” said Sheila Tan, Chief Commercial Officer at OrthoFX. “Shorter treatment times, fewer aligners, and greater precision aren’t just numbers. They ladder up to happier patients and greater practice efficiency. We’re especially proud that this comparison was conducted under controlled conditions by the same clinician using identical protocols, because it reflects what’s really driving the difference: the proprietary polymer innovation behind our aligner system.”

Tan added, “This study is an important step in demonstrating that FXClear is not simply another aligner alternative; it’s the next generation of aligner innovation and a clinically differentiated system built to raise the standard of care in orthodontics.”

Study Methodology

The retrospective observational study evaluated patients aged 14 and older with mild-to-moderate malocclusion complexity (ABO DI scores between 10 and 30) treated at three private orthodontic practices by the same provider. All patients were treated with nonextraction approaches. Treatment effectiveness was assessed through digital superimposition of initial scans, final intraoral scans, and computerized treatment plan STL files using Geomagic Control X and Meshmixer software. Modified ABO OGS scores were used to grade final outcomes. Statistical analysis employed independent-samples t-tests and Mann–Whitney U tests at p<.05. The full study is ongoing and the manuscript is being prepared for submission to a leading orthodontic journal.

About OrthoFX

OrthoFX was established by pioneers in the clear aligner industry who helped advance and scale leading aligner brands. The founders saw an opportunity to improve predictability and patient compliance by reimagining next-generation polymers, software, and services. The OrthoFX portfolio includes FXClear, featuring stain-resistant material and smooth, scalloped edges; FXBright, a translucent aligner system that offers a naturally whiter appearance from day one; and the AirFlex System with newly announced PrecisionFinish aligners.

For more information about becoming an OrthoFX provider, visit www.orthofx.com.

Spear Education Highlights Growth Across Education, Partnerships, and Events Following Spear Summit 2026

2026-04-28T13:46:00.004-04:00

Increased global engagement and new programming reflect demand for practical,
outcomes-focused training

SCOTTSDALE, Ariz., April 14, 2026 /PRNewswire/ -- Spear Education, the leading provider of advanced dental training and dental workforce enablement solutions, is building on strong momentum in 2026, with growth driven by Spear Summit results, expanded partnerships, and new programming.

This year's summit drew a global community of clinicians and provided dedicated time to connect and network. Internationally recognized dentists from Brazil, Germany, and Italy led seminars and discussions. Attendees were also inspired by Dr. Frank Spear's session titled "What Are You Going to Do with the Rest of Your Life?" along with the broader curriculum focused on clinical excellence, decision-making, and practice growth. Spear Summit once again attracted a highly engaged audience, with 94% of attendees reporting a positive overall experience.

"We are seeing a strong response from dentists who are looking for clarity in how they grow and how they can effectively manage and retain their teams," said Matthew Coggin, chief executive officer of Spear Education. "Summit is where those conversations happen in a meaningful way. We want to partner with them to reach their ideal practice and support them with clinical learning, but also support in the form of leadership training, team learning pathways and coaching so they can build the practice and business they want."

In addition to the positive response to this year's Spear Summit, Spear Education has been focused on expanding its partner relationships and product growth. In Q1 of this year, the company deepened its work with Overjet and Align Technology, further supporting clinicians with integrated tools and education that connect clinical care with emerging technologies.

Alongside these partnerships, Spear has introduced several new and expanded learning experiences in addition to releasing a reimagined learning platform in early Q1. Spear Online has been updated to offer a new online learning experience that offers personalized learning pathways, improved navigation, and expanded course content for dentists at every stage of their careers.

"Our focus is on giving dentists and their teams practical ways to improve both clinical outcomes and the business side of their practice," said Dr. Dan Butterman, chief dental officer at Spear Education. "That includes everything from restorative planning to financial decision-making. The goal is to meet clinicians where they are and give them a clear path forward."

The next Spear Summit will take place April 7–10, 2027, at the JW Marriott Grande Lakes in Orlando, Fla.

Dentists can explore Spear Education's platform and create a free Discover account at https://account.speareducation.com/register.

About Spear Education
Spear Education is the leading provider of advanced dental training and dental workforce enablement solutions, equipping dentists and their teams with the clinical and leadership capabilities needed to enhance patient care and grow their practices. Through a blend of tech-enabled virtual learning, hands-on workshops, live seminars, and study clubs, the company is committed to advancing modern dentistry at every level. For more information, visit www.speareducation.com.

SOURCE Spear Education

OraLiva, Inc. Announces Launch of Clinically Validated, AI-Powered Oral Cancer Test

2026-04-27T13:43:00.006-04:00

OraLiva, Inc. announced the commercial launch of its AI-powered oral cancer and oral lesion test, a powerful non-invasive test designed to empower dentists and clinicians to detect and monitor lesions of concern earlier, when outcomes are most favorable. OraLiva has partnered with Delta Dental Plan of Michigan, Inc., Delta Dental Plan of Ohio, Inc., Delta Dental Plan of Indiana, Inc. (collectively “DDMI”), and Delta Dental of North Carolina (“DDNC”)¹ on the launch to make the test available as a covered procedure.

The test, a “thermometer for cancer,” is intended for use by dentists, periodontists, oral and maxillofacial surgeons, and ENTs. Samples are collected quickly with a simple brush of the lesion during a routine clinical visit by hygienists or dentists. OraLiva’s test can also be used in surveillance testing of high-risk or recurrent patients and similarly be collected by nurses, trained assistants, or specialists.

Built on one of the largest NIH-sponsored prospective studies of oral potentially malignant disorders ever completed, with 999 patients and more than 13 million analyzed cells, OraLiva has developed and clinically validated one of the most advanced cytology models for the early detection and monitoring of oral cancer, uniquely capable of accurately distinguishing mild, moderate, and severe oral epithelial dysplasia (i.e., pre-cancer).²

Oral Cancer: Hiding in Plain Sight

Despite being visible in routine dental examinations, oral cancer remains one of the most difficult cancers to detect early because many benign oral lesions share features with oral epithelial dysplasia. This diagnostic challenge is compounded by the lack of effective, readily available tools to guide front-line clinicians when evaluating suspicious lesions.

In 2025, an estimated 59,660 Americans will be diagnosed with oral cancer, and approximately 12,770 will die from the disease.³ Unfortunately, only one in four cases of oral cancer are detected at an early stage, where five-year survival approaches 88%. Most cases are diagnosed at later stages of disease, when survival drops to approximately 37%, underscoring the urgent need for better early-identification tools.⁴

OraLiva’s test is designed not only to support the proactive detection of cancerous lesions but also to intercept disease earlier at the stage of precancerous dysplasia, when treatment is less invasive, survival prospects are higher, and healthcare costs are significantly lower.

A New Cytomics Platform for Early Detection

OraLiva’s test is powered by a novel cytomics platform that combines advanced microfluidics, high-resolution cellular imaging, and artificial intelligence to analyze cellular changes associated with early cancer development.

After collection by the provider, samples are shipped to OraLiva’s lab, where a proprietary microfluidic cartridge prepares the sample for digital cytology analysis. Once processed, the system generates high-resolution cellular images using OraLiva’s proprietary cellular imaging device, designed to capture detailed morphological and biomarker information from individual epithelial cells.

These images are analyzed by AI models trained on millions of oral epithelial cells and mapped to gold-standard adjudicated stages defined by leading oral pathologists. The models evaluate subtle cellular patterns associated with dysplasia and malignancy, enabling the system to detect abnormalities beyond the detection of the human eye.

The resulting test report, reviewed and approved by a pathologist, includes both a quantitative risk score, which measures the risk of the lesion, and an actionable recommendation to the provider on whether to rule out, monitor, or refer patients.

The technology was developed through more than a decade of translational research led by Dr. John T. McDevitt at the NYU College of Dentistry, in collaboration with experts in oncology, pathology, and biomedical engineering.

Access to Early Detection

OraLiva has partnered with Delta Dental of Michigan, Indiana, Ohio, and North Carolina to make the test available to providers in those states as a covered procedure under CDT code D7288 (brush biopsy, transepithelial sample collection). OraLiva expects to expand availability to additional states throughout the year as the program grows.

Dental providers interested in evaluating the technology in their practice can sign up for clinical evaluation kits here.

About OraLiva, Inc.

OraLiva develops AI-powered cytology diagnostics for early detection across epithelial tissues. Its oral lesion test combines microfluidic cytology collection, digital imaging, and artificial intelligence to generate clinically validated, risk-stratified reports and actionable recommendations that support clinical decision-making.

REFERENCES

Delta Dental is a trademark of the Delta Dental Plans Association. The Delta Dental Plans Association does not make any representations, warranties or endorsements with respect to OraLiva or its products
McRae, McDevitt, Journal of Dental Research, 2021, 100, 479-486.
https://www.cancer.org/cancer/types/oral-cavity-and-oropharyngeal-cancer/about/key-statistics.html
https://www.cancer.org/cancer/types/oral-cavity-and-oropharyngeal-cancer/detection-diagnosis-staging/survival-rates.html

vVARDIS Announces Investment from Apollo —Achieves Unicorn Status

2026-04-27T13:12:00.002-04:00

Investment will support global commercial expansion of the Curodont™ technology platform, the first and only non-invasive peptide-containing formulations designed to treat tooth decay drill-free throughout the depth of the lesion.

ZUG, Switzerland – April 27, 2026 – vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”).

The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few privately owned, billion-dollar-plus, healthcare companies. vVARDIS’ founders and co-CEOs, Drs. Haley and Goly Abivardi, will retain a substantial majority shareholding in the company.

vVARDIS is redefining the treatment of cavities through its Curodont™ technology, the first and only commercially available non-invasive peptide-containing formulations clinically proven to treat tooth decay.

Curodont™ supports enamel repair by facilitating the formation of crystalline mineral structure throughout the affected area, giving dental professionals an easy-to-use, restorative option to treat early-stage cavities as an alternative to traditional drilling.

Since the launch of Curodont™ Repair Fluoride Plus in the U.S. over two years ago, it has been used to treat approximately 3 million teeth, is now present in nearly 20 percent of general dental practices nationwide1 and is one of the fastest-growing dental products in the U.S.2.

“vVARDIS has built a differentiated business, with Drs. Haley and Goly Abivardi pioneering a new category in dental care backed by peer-reviewed clinical studies,” said Jeremy Honeth, Partner and Andrea Vanni, Managing Director at Apollo. “Apollo Funds’ investment supports the company’s continued expansion in key markets across the US and Europe, bringing this restorative therapy to more practices and patients worldwide.”

“Curodont™ fills a longstanding gap in dentistry: when prevention fails, dentists now have a quick, easy-to-use non-invasive treatment free of drilling and needles. The rapid adoption of Curodont™ reflects the urgency of that unmet need,” said Haley Abivardi, DMD, co-CEO and co-founder of vVARDIS. “Apollo Funds’ investment strengthens our commercial foundation in the US and Europe and enables us to scale this environmentally sustainable technology across markets.”

Goly Abivardi, DMD, co-CEO and co-founder of vVARDIS, said, “Our mission is to bring a medical, science driven approach to dentistry. Using peptide-containing formulations, our non-invasive technology is an innovative treatment designed to treat tooth decay without drilling and without polymer materials. Apollo Funds’ investment reinforces our leadership in generative dentistry and advances the future of oral science.”

Tooth decay is the world’s most prevalent non-communicable disease, affecting nearly 90 percent of US adults. Oral health is closely linked to overall health, and untreated cavities can contribute to serious chronic conditions, including a 26 percent increased risk of all-cause mortality.3. Recently published WHO guidelines reinforce vVARDIS’ mission of early intervention and non-invasive care, as the company targets an addressable market of over $30 billion in the US.

The financial terms of the transaction were not disclosed.

About vVARDIS AG

vVARDIS is a disruptive Swiss healthcare company in the dental med-tech sector headquartered in Zug, Switzerland that offers groundbreaking, non-invasive solutions for dental professionals with the Curodont™ brand of products. Founded by Drs. Haley and Goly Abivardi, DMDs, sisters, internationally renowned dentists, innovators and self-made serial entrepreneurs, vVARDIS is the result of more than 25 years of research, paired with the commitment of its founders to make an impact on people's lives, especially the underserved.

vVARDIS' mission is to expand access to novel approaches that create new standards of care in dentistry with the purpose of improving oral health – the foundation for overall health. Backed by 25 years of research and more than 10 years of use in clinical practices globally, vVARDIS’ products and science are supported by more than 250 scientific publications, including meta-analysis, peer-reviewed and long-term peer-reviewed real-world evidence clinical studies, with a documented success rate above 90%. Curodont™ products are already presented in the lectures of renowned universities as a standard of care for the treatment of early decay. vVARDIS was awarded the 2026 Innovative Company of the Year and is a member of the World Economic Forum Innovator Communities. For more information, visit vVARDIS at www.vVARDIS.com and www.linkedin.com/company/vvardis .

About Apollo

Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions provider to institutions. Our patient, creative, and knowledgeable approach to investing aligns our clients, businesses we invest in, our employees, and the communities we impact, to expand opportunity and achieve positive outcomes. As of December 31, 2025, Apollo had approximately $938 billion of assets under management. To learn more, please visit www.apollo.com.

References:

1 Data on file

2 vVARDIS’ ranked first in growth rate in the 2024 vs 2023 and YTD June 2025 periods among dental manufacturers with more than $1M sales in both the all merchandise & small equipment categories and preventive in the U.S. (Source: SDM Northcoast, LLC).

3 Liu J et al. Int J Epidemiol. 2022;51:1291-1303

Photo credit: Jos Schmid, Photographer

A-dec Funds $1M Dental Scholarship Endowment

2026-04-24T13:42:00.006-04:00

The Dental Trade Alliance Foundation recently announced a transformative $1,000,000 endowment from A-dec, a leading global manufacturer of premium dental equipment and solutions and a DTA member company. This donation has established the A-dec Scholarship Fund, a permanent endowment designed to support education by providing scholarships for dental and dental hygiene students.

The endowment will provide ongoing financial support for students who demonstrate a strong commitment to serving their communities and expanding access to oral healthcare for underserved populations.

The gift represents one of the largest individual contributions to the Foundation’s scholarship initiatives to date and reinforces a shared commitment to advancing oral health through education, service, and leadership.

“Education and service are fundamental to strengthening oral healthcare in communities across the country,” said Jackie Michaels, managing director of the Dental Trade Alliance Foundation. “This generous endowment from A-dec will support future dental and dental hygiene professionals who are dedicated not only to clinical excellence but also to ensuring access to care for those who need it most.”

Through this endowment, scholarship funds will be awarded annually to students pursuing careers in dentistry and dental hygiene who demonstrate leadership, community involvement, and a passion for improving access to oral healthcare.

“Education is fundamental to advancing dentistry,” said Marv Nelson, chief executive officer of A-dec. “By supporting the next generation of dental professionals, we are helping build a stronger, more accessible future for oral healthcare.”

The Dental Trade Alliance Foundation works to strengthen the dental industry through education, charitable initiatives, and workforce development programs. The Foundation provides scholarships, community outreach programs, and initiatives designed to improve oral health outcomes and support the future of the profession.

More information about the Foundation and its programs can be found at: https://dtafoundation.org.

Additional details about the A-dec Scholarship Fund will be announced as the program launches.

About the Dental Trade Alliance Foundation

The Dental Trade Alliance Foundation supports initiatives that advance oral health, strengthen the dental workforce, and expand access to care. Through scholarships, educational programs, and community partnerships, the Foundation invests in the future of dentistry and the professionals who serve patients across the country.

About A-dec

A-dec is a leading manufacturer of dental equipment and solutions used by dental professionals worldwide. For more than 60 years, A-dec has been committed to supporting the dental profession through innovation, education, and industry leadership.

To learn more about the vision behind the A-dec Scholarship Fund, watch “Empowering the Next Generation of Dental Professionals | A-dec + DTA Foundation.”

The Benefits and Challenges of SLS in Dental Products

2026-04-23T16:38:00.006-04:00

You may have noticed that more and more of your patients have started seeking toothpastes that are free of Sodium Lauryl Sulfate (SLS). Why has this become a trend, and what are your patients’ concerns? Here’s what you need to know.

What Is SLS?

Sodium lauryl sulfate (SLS) is a surfactant commonly used as a foaming agent in oral care products such as toothpastes and mouthwashes. Surfactants lower surface tension, allowing ingredients to spread more easily and interact with debris on tooth surfaces and oral tissues.

Because SLS creates a rich foam, many people assume that the foam itself enhances the product’s cleaning power. In reality, foam is largely a sensory byproduct of the surfactant’s action and does not directly improve cleansing efficacy. Debris removal is driven by the surfactant’s ability to interact with and lift particles, not by the foam itself.

In the United States, SLS is permitted for use in oral care products and is regulated by the U.S. Food and Drug Administration (FDA) under cosmetic and over-the-counter drug guidelines, depending on the product classification. When used at approved concentrations (typically 1-3%), SLS is considered safe for the general population. However, some individuals may experience irritation or sensitivity, particularly those with recurrent aphthous ulcers or mucosal sensitivity.

How Can SLS Affect Patients?

Many dental patients prefer products containing SLS because they associate foaming with cleanliness. They may also appreciate the familiar taste and the typically lower cost of SLS-containing formulations.

Studies have shown, however, that some patients have negative reactions to brushing with a toothpaste formulated with SLS. These effects have included oral lesions¹, inflammatory reactions of the anterior dorsal tongue², and oral mucosal desquamation³, or the peeling of the mouth’s lining. Especially for patients who are prone to mouth or tooth sensitivity, SLS products can exacerbate oral health issues rather than improve them.

Alternatives for Sensitive Patients

SLS remains an effective and FDA-approved surfactant that performs well in many toothpaste formulations. For patients without a history of mucosal sensitivity, aphthous ulcers, xerostomia, or irritation, an SLS-containing toothpaste may be perfectly appropriate and cost-effective. The presence of foam can also enhance patient satisfaction and perceived cleanliness, which may positively influence brushing compliance.

However, for patients who report recurrent canker sores, burning sensations, tissue sloughing, or generalized oral sensitivity, recommending an SLS-free formulation may be a simple and impactful modification. In these cases, reducing potential irritants can improve comfort and support long-term adherence to oral hygiene routines.

Ultimately, the decision should be patient-specific. Understanding both the functional role of SLS and the growing consumer preference for gentler formulations allows dental professionals to guide recommendations based on individual risk factors, clinical presentation, and patient comfort rather than marketing trends alone.

Many of the leading manufacturers of dental products make SLS-free formulas, which are often marketed for sensitive patients. TheraBreath™ Sensitive Toothpaste falls into this category, and follows the company’s philosophy of using intentionally sourced, effective ingredients. Its active ingredients are potassium nitrate 5% and sodium fluoride 0.24% (0.16% w/v fluoride ion), for caries prevention.

Sensitive Toothpaste uses several inactive ingredients, including Sodium Methyl Cocoyl Taurate, a gentle surfactant derived from coconuts, and sodium bicarbonate, commonly called baking soda. The formula whitens sensitive teeth without harsh abrasives. Patients can also enjoy long-lasting fresh breath.

Reviews of the Sensitive Toothpaste formula say it’s enjoyable and effective:

“As a dental hygienist I love to try new products to be able to recommend to my patients when needed. I have received this product at the right time. My husband was having sensitivity on a tooth, and I let him try this toothpaste. After two days of use, sensitivity went away. Definitely fast action!”

“The TheraBreath™ Sensitive Toothpaste has a great texture and taste. There’s no bad aftertaste and it felt gentle. It also didn’t cause dry mouth after like some other toothpastes I’ve tried before.”

“I can’t use a lot of toothpastes because I am allergic to SLS. The issue with a lot of SLS-free toothpastes is that they just aren’t very minty and don’t feel fresh. This toothpaste is SLS-free and has that fresh minty taste that I love.”

Sensitive Toothpaste is the latest addition to the TheraBreath™ line of dentist-formulated toothpastes for every patient need, from caries prevention and gum health to fresh breath and whitening. Each formula contains no alcohol, parabens, dyes, andsulfates. Patients’ dietary preferences are also taken into consideration, as all TheraBreath™ formulas are certified vegan, kosher, and halal.

Weiger R, Netuschil L, von Ohle C, Brecx M. Microbial vitality of supragingival dental plaque during initial stages of experimental gingivitis in humans. J Periodontal Res. 1995; 30: 204–209. doi: 10.1111/j.1600-0765.1995.tb01275.x
Steinberg D, Bachrach G, Gedalia I, Abu-Ata S, Rozen R. Effects of various antiplaque agents on fructosyltransferase activity in solution and immobilized onto hydroxyapatite. Eur J Oral Sci. 2002; Oct;110(5):374-9. doi: 10.1034/j.1600-0722.2002.21303.x
Bowden GH, Hamilton IR. Survival of oral bacteria. Crit Rev Oral Biol Med. 1998;9(1):54–85. doi: 10.1177/10454411980090010401

JOMS Study: Steroid Given During Wisdom Tooth Surgery May Help Patients Rely Less on Opioids

2026-04-23T15:20:42.042-04:00

AAOMS-published research links single-dose IV steroid to lower pain in the first 24 hours

A new study in a recent issue of the Journal of Oral and Maxillofacial Surgery (JOMS) reports that a single intravenous (IV) dose of dexamethasone—a commonly used anti-inflammatory steroid—given during wisdom tooth surgery was associated with less pain in the first 24 hours after the procedure, when discomfort typically peaks.

Published in the official peer-reviewed journal of the American Association of Oral and Maxillofacial Surgeons (AAOMS), the study adds to the evidence supporting pain-control plans that prioritize non-opioid options after routine third molar removal.

Researchers found that patients who received IV dexamethasone experienced less pain on the first day after surgery, whether they later took non-opioid pain relievers such as ibuprofen and acetaminophen or an opioid. The lowest pain scores occurred among patients who used non-opioid pain relievers after receiving the steroid.

The results align with national efforts to encourage non-opioid, multimodal pain-control plans for routine procedures, particularly for young adults who may receive their first opioid prescription because of third molar removal.

“These findings support the incorporation of intra-operative IV dexamethasone alongside postoperative NSAIDs and acetaminophen as part of a multimodal approach to pain management, potentially reducing the need for opioid prescriptions in routine third molar surgery,” the study’s authors said.

Supported by the multicenter Opioid Analgesic Reduction Study (OARS), the analysis contributes to ongoing work to refine postoperative pain protocols for one of the most common in-office procedures performed by oral and maxillofacial surgeons (OMSs). Effective postoperative pain management remains a critical component of successful wisdom tooth surgery.

KEY FINDINGS

Researchers asked patients to rate their pain on a 0 to 10 scale (0 = no pain; 10 = worst pain imaginable) in a simple electronic diary during the first few days after surgery. After accounting for differences between patients and procedures, the study showed:

Patients who received IV dexamethasone during surgery reported less pain on the first postoperative day, whether they were taking non-opioid medicines or an opioid after surgery.

The group that used non-opioid pain medicine plus the in-surgery steroid reported the lowest pain scores overall across the time points measured.
Over the full recovery period tracked, the non-opioid-plus-steroid group still had the lowest average pain scores, though the overall difference compared with non-opioids alone was relatively small.

The authors of “Does Intra-Operative IV Dexamethasone Reduce Postoperative Pain More Effectively With Nonopioids or Opioids?” are Ryan Look, DMD; Vincent B. Ziccardi, DDS, MD; and Janine Fredericks-Younger, DMD, all of the Rutgers School of Dental Medicine in Newark, N.J.; Tracy Andrews, MS; and Patricia Greenberg, MS, of Rutgers University in Newark, N.J.; and the OARS Study Group.

Access the full article at JOMS.org/article/S0278-2391(25)00810-9/fulltext.

For more information on wisdom teeth management, visit MyOMS.org/What-We-Do/Wisdom-Teeth-Management.

LEARN MORE

Previous JOMS research supporting non-opioid-focused pain-control strategies after routine third molar removal includes:

A 2021 scoping review, “Pharmacological and Non-Pharmacological Methods of Postoperative Pain Control Following Oral and Maxillofacial Surgery: A Scoping Review,” found that COX-2 inhibitors, anti-inflammatory pain relief medications such as celecoxib, may reduce postoperative pain more effectively than NSAIDs such as ibuprofen. Read the abstract at JOMS.org/article/S0278-2391(21)00408-0/abstract.
A 2021 retrospective study, “A Retrospective Cross-Sectional Study of the Effect of Liposomal Bupivacaine on Postoperative Opioid Prescribing After Third Molar Extraction,” reported that patients who received liposomal bupivacaine, a long-lasting local anesthetic, required fewer opioid pills after wisdom-tooth surgery and were less likely to need a refill. Read the full article at JOMS.org/article/S0278-2391(21)00188-9/fulltext.

In 2025, AAOMS reaffirmed its non-opioid-first guidance in “Opioid Prescribing: Acute and Postoperative Pain Management,” which recommends ibuprofen—rather than opioids—as the preferred first-line therapy for acute and postsurgical pain.

About the Journal of Oral and Maxillofacial Surgery (JOMS)

The Journal of Oral and Maxillofacial Surgery is published by AAOMS to present to the dental and medical communities comprehensive coverage of new techniques, important developments, and innovative ideas in oral and maxillofacial surgery. Practice-applicable articles help develop the methods used to handle dentoalveolar surgery, facial injuries and deformities, TMJ disorders, oral and head and neck cancer, jaw reconstruction, anesthesia, and analgesia. The Journal also includes specifics on new instruments and diagnostic equipment, and modern therapeutic drugs and devices.

About AAOMS

The American Association of Oral and Maxillofacial Surgeons (AAOMS) represents more than 9,000 oral and maxillofacial surgeons in the U.S. AAOMS surgeons specialize in treating diseases, injuries, and defects of the mouth, jaw, and face. Learn more at AAOMS.org.

Pearl Launches AI Assistant for Dental Documentation

2026-04-22T08:27:00.004-04:00

Pearl, the global leader in dental AI solutions, recently announced Pearl Voice, an AI assistant for clinical documentation designed specifically for dental practices. Pearl Voice automatically captures and transcribes doctor–patient interactions during appointments and converts them into structured clinical documentation, including SOAP notes, periodontal charts, and other dental-specific formats, helping providers maintain complete and accurate records in real time.

Pearl Voice turns doctor-patient conversations into structured clinical notes and chart-ready documentation, reducing administrative burden enabling clinicians to focus on quality care.

Documentation remains one of the most time-consuming aspects of dental practice. By automatically transforming chairside conversations into structured clinical notes, Pearl Voice allows dentists to stay focused on patient care while ensuring that clinical records are complete, compliant, and ready for practice management system (PMS) ingestion.

“Scribing and charting are essential to high-quality care, but the manual documentation process pulls providers away from the patient and often extends the workday for clinicians,” said Ophir Tanz, founder and CEO of Pearl. “Pearl Voice captures the clinical encounter as it happens, making the output, whether a doctor’s notes on a patient visit or a hygienist’s measurements in a perio exam, more complete and accurate. The time savings are significant, and dentists can reinvest time saved into patient communication and care, where their expertise matters most.”

Pearl Voice listens passively during appointments and intelligently synthesizes relevant clinical details in standardized formats used by dental providers and insurers. Key capabilities of Pearl Voice include:

Ambient Listening, Transcription, and AI-Generated Clinical Notes: Captures and transcribes natural doctor–patient conversations, even as clinicians navigate between screens. Converts transcriptions into accurate and structured clinical notes for complete, consistent documentation.
Voice-Enabled Perio Charting: Charts perio measurements in real time based on spoken input from providers, eliminating the need for manual transcription by dental assistants. Hands-free voice commands allow quick updates, corrections, and navigation between teeth on the chart.
30+ Procedure-Specific Templates: Applies customizable procedure templates to ensure that generated notes meet the specific documentation requirements and individual provider preferences for numerous clinical scenarios, including exams, fillings, crowns, scaling and root planing, root canals, and extractions.
Background Recording: Ensures uninterrupted clinical workflows and documented patient interactions by continuing to record even as users navigate between screens.
Defense Against Claim Challenges and Litigation: Provides practices with detailed clinical narratives that support treatment decisions against “insufficient documentation” claims, as well as malpractice suits or board audits.
Practice Management System Integration: Writes structured notes directly into supported practice management systems (PMS), eliminating duplicate entry and simplifying record management.

By automating documentation, Pearl Voice helps dental providers reduce administrative workload while improving the consistency and quality of clinical records. Voice-enabled perio charting, for example, significantly streamlines the hygiene workflow, allowing providers to complete accurate, detailed periodontal exams faster and freeing dental assistants, who traditionally chart the hygienist’s measurements manually, to focus on other crucial tasks. Early adopters report significant time savings and improved documentation standardization across providers.

“The documentation workflow in our office has improved dramatically since implementing Pearl Voice,” said Dr. Daniel Naysan, a dentist at Bedford Dental Group. “I’m saving at least 60 minutes a day, and my notes are cleaner. They’re also more standardized across my partners, so there’s more fluid patient handoff between us and broadly better compliance with clinical documentation requirements.”

With Pearl Voice, Pearl continues to expand its AI platform beyond radiologic analysis to support clinical workflows across dental practices. By connecting diagnosis, documentation, and operational systems, Pearl is delivering integrated AI infrastructure that elevates care and patient experiences, while enabling more efficient, productive dentistry by reducing friction between clinical insight and administrative execution.

“We see AI as the key to taking the friction out of the entire dental care journey, from initial diagnosis and documentation all the way through to treatment delivery,” Tanz added. “Pearl Voice is a central part of the broader, smarter, and more efficient end-to-end AI platform we’re building to empower better dentistry.”

For more information or to request a demo, visit hellopearl.com/voice.

About Pearl

Pearl is a dental AI company committed to enhancing how patient care is delivered. Founded in 2019 by a team with decades of experience developing successful, enterprise-grade computer vision solutions, Pearl introduced the first-ever FDA-cleared AI capable of reading and instantly identifying diseases in dental X-rays. With regulatory clearance in 120 countries, Pearl’s AI assists dentists in making precise clinical decisions and effectively communicating with patients, thereby transforming the dental care experience worldwide. As dentistry’s global AI leader, Pearl is committed to the ongoing innovation of robust, accessible AI tools that improve patient health outcomes and build greater trust in dental medicine. To request a demo, please visit hellopearl.com/demo.

Ultradent Partners to Expand Facial Esthetics Education

2026-04-21T08:55:00.008-04:00

Ultradent Products, Inc., a leading developer and manufacturer of high-tech dental materials, is partnering with the American Academy of Facial Esthetics (AAFE) and StatDDS to support facial esthetics education and product solutions for dental professionals who want to expand their clinical offerings.

AAFE is the industry leader in botulinum toxin, dermal filler, and TMJ injection therapy training for dentists. StatDDS equips dentists and healthcare professionals with the pharmaceuticals and supplies essential for both therapeutic and esthetic procedures. This new partnership enhances visibility and streamlines the journey for clinicians seeking trusted education and reliable product solutions in facial esthetics.

As dental professionals continue to expand their practices beyond traditional restorative procedures, facial esthetics presents an opportunity to grow while maintaining clinical excellence. By aligning with AAFE, which has trained over 20,000 dentists, and StatDDS, Ultradent supports practitioners in accessing nationally recognized certification training and dependable product fulfillment.

“Clinicians are always looking for meaningful ways to expand their skill sets and better serve their patients,” says Dirk Jeffs, President and CEO of Ultradent Products, Inc. “By partnering with AAFE and StatDDS, we are supporting trusted education and product access in facial esthetics, ultimately helping more patients reach their goals. This collaboration allows each organization to do what it does best—educate, fulfill, and support—so clinicians can confidently grow their practices.”

“Our focus has always been on helping dentists successfully integrate facial esthetics into their practices,” says Dr. Louis Malcmacher, MAGD, President of AAFE. “It’s not just about learning techniques, but implementing them in a way that drives real results for both patients and the practice. Partnering with Ultradent allows us to extend that impact by aligning world-class education with trusted clinical products, giving dental practices a more direct path to success.”

About Ultradent Products, Inc.

Ultradent Products, Inc., is a leading developer and manufacturer of high-tech dental materials, devices, and instruments worldwide. Ultradent’s vision is to improve oral health globally. Ultradent also works to improve the quality of life and health of individuals through financial and charitable programs.

For more information about Ultradent, call 800.552.5512 or visit ultradent.com.

Planet DDS Launches AI Voice Charting Tool

2026-04-20T13:48:00.006-04:00

Following AI Voice Perio, voice-driven charting expands to restorative exams, enabling single-provider clinical documentation in Denticon.

Planet DDS recently announced the launch of AI Voice Restorative Charting, the newest capability in the Clinical Voice+ Suite. Building on AI Voice Perio, AI Voice Restorative Charting extends voice-driven documentation to the highest-volume clinical task in general dentistry: capturing decay, existing restorations, fractures, and treatment plan entries during the restorative exam.

Designed for dental support organizations (DSOs) and multi-location dental groups, the solution allows a single clinician to document findings in real time. This reduces the need for a dedicated chairside scribe and helps clinical teams move through appointments with fewer interruptions.

“AI Voice Perio proved that voice-driven clinical documentation can work at scale inside Denticon,” said Nathan James, Chief Product Officer of Planet DDS. “AI Voice Restorative Charting takes that same model and extends it to where most of the charting volume actually lives. Practices have long accepted that restorative documentation requires two people or workarounds. We’re giving them a better option: one provider, charting by voice, in the same system they already use.”

Extending the AI Voice Clinical+ Suite

Both AI Voice Restorative Charting and AI Voice Perio share the same underlying infrastructure, voice capture model, and governance controls within Denticon, providing organizations with a unified approach to clinical documentation across exam types. Restorative findings, such as perio data, are captured during the exam and entered directly into the system of record.

The restorative charting workflow recognizes dental terminology, abbreviations, and compound commands in natural speech. A real-time voice overlay panel displays what is captured as providers speak, and voice corrections such as “Undo,” “Clear tooth 14,” or “Change that to amalgam” can be made mid-exam without touching the keyboard.

Key Features of AI Voice Restorative Charting:

Voice-activated restorative charting: Providers can capture decay, existing restorations, fractures, implants, and treatment plan entries without interrupting the exam.
Single-provider workflow: Reduces reliance on a chairside scribe, allowing dentists to chart independently and freeing clinical staff for direct patient support.
Real-time capture and corrections: A voice overlay panel shows what is captured as providers speak, with voice commands available for in-exam corrections. Nothing is auto-decided; the clinician remains in full control.
Standardized documentation governance: Restorative findings are captured in a consistent workflow inside Denticon, supporting more comparable records across providers and locations, stronger confidence in clinical reporting, and a lower audit burden as organizations grow.

How AI Voice Restorative Charting Benefits DSOs

By capturing documentation in the moment, AI Voice Restorative Charting supports consistency, reduces the training burden associated with documentation variability, and improves confidence in clinical reporting and audits over time.

AI Voice Restorative Charting is now available to Denticon customers. Throughout 2026, Planet DDS will continue expanding AI-powered clinical capabilities across DentalOS™, with launches such as AI Voice Treatment Plan and AI Ambient Voice coming soon.

Resources:

To learn more about AI Voice Restorative Charting or request a demo, visit https://www.planetdds.com/.

About Planet DDS

Dental software is broken. We aim to fix it. As a partner in growth for DSOs and dental groups outgrowing legacy systems and fragmented tools, Planet DDS delivers a cloud-based AI platform designed to scale alongside growing organizations.

Powered by DentalOS™ with AI, Planet DDS is built on connection—connecting people, partners, and technology across an open ecosystem that includes Denticon Practice Management, Cloud 9 Ortho Practice Management, and Apteryx Cloud Imaging. Trusted by leading DSOs and emerging dental groups nationwide, Planet DDS supports more 100+ location DSOs than any other cloud-based dental practice management provider, enabling 14,500 practices and 175,000 users to move beyond outdated legacy software with seamless integrations, optimized workflows, and scalable technology built for growth.

DentScribe Launches Treatment Coordinator Notes Workflow

2026-04-17T12:14:00.003-04:00

New agentic workflow converts post-appointment patient conversations into structured financial notes, follow-up actions, and business insights.

DentScribe, the AI platform for dental documentation and production, today announced DentScribe Treatment Coordinator Notes, a new agentic AI workflow designed for one of the most important moments in the patient journey: the post-appointment conversation at the front desk. The new capability helps dental practices transform treatment coordinator discussions into structured internal notes, clearer follow-up actions, and actionable business intelligence that can improve case acceptance, patient communication, and production.

In dental practices, the handoff from provider to treatment coordinator often determines whether treatment is understood, scheduled, financed, and completed. These conversations typically cover recommended treatment, urgency, phased care, financial responsibility, payment options, insurance limitations, appointment timing, patient objections, and next steps. Yet in many offices, this business-critical discussion remains inconsistently documented and difficult to analyze at scale.

DentScribe Treatment Coordinator Notes is built to solve that problem.

Using DentScribe’s agentic AI foundation, the workflow captures and structures the post-appointment conversation between the patient and the treatment coordinator, business team member, or scheduling coordinator. It then organizes the discussion into operationally useful sections such as treatment plan review, financial discussion, payment options, scheduling, objection handling, emotional and motivational support, and follow-up actions.

The result is a clear internal record of what was explained, what concerns the patient raised, what options were discussed, and what the practice needs to do next.

Key Advantages

Standardizes treatment coordinator documentation by turning complex front-desk conversations into structured internal notes.
Improves follow-through by clearly capturing objections, hesitation, payment needs, scheduling status, and next-step commitments.
Creates new business visibility by surfacing patterns in cost concerns, insurance friction, financing needs, and unscheduled treatment.
Supports coordinator coaching and consistency by helping practices understand which conversations lead to progress and which ones stall.
Extends DentScribe’s ground-truth model beyond the operatory by applying AI not only to clinical documentation but also to the administrative and financial conversation that drives treatment completion.

“DentScribe’s ground-truth approach, which mines SOAP notes for action, sets the standard for AI in dentistry. We’re excited to partner with advisors and customers to scale this impact across practices and DSOs,” said Dr. Ratinder Paul Singh Ahuja, Board Chair of DentScribe.

“We built DentScribe to let dentists be fully present with patients while AI handles the documentation, and now those same workflows can support the treatment coordinator conversation, turning it into a reliable engine for care delivery and production,” said Dr. Vinni K. Singh, Founder & CEO of DentScribe.

DentScribe Treatment Coordinator Notes builds on the company’s broader platform for dental documentation and production. DentScribe automatically generates comprehensive SOAP notes from dentist-patient conversations, converts those notes into chairside action with DentScribe CoPilot, and turns daily clinical priorities into production workflows with DentScribe GPS (Guided Production System). With Treatment Coordinator Notes, DentScribe now extends that same agentic system into the front-office workflow, where treatment acceptance, financial clarity, and patient follow-up are often won or lost.

How It Works

AI captures and structures the post-appointment treatment coordinator discussion.
Notes organize the conversation into actionable categories, including treatment review, finances, payment options, scheduling, objections, and follow-up.
Teams gain a cleaner internal record of what was discussed and what remains unresolved.
Practice leaders gain insight into recurring patient concerns, coordinator performance patterns, and missed production opportunities.

The new workflow is designed for general practices, specialty offices, and DSOs that want more consistent patient handoffs, better documentation of financial conversations, and stronger visibility into the operational factors that affect treatment completion.

Book a demo: www.dentscribe.ai/book-a-demo

About DentScribe

DentScribe is the AI platform for dental documentation and production. DentScribe automatically generates comprehensive SOAP notes from dentist-patient conversations and publishes them directly into leading practice management systems. With DentScribe CoPilot, those notes become chairside checklists that close care gaps and increase case acceptance. With DentScribe GPS, leaders gain a practice-wide daily brief that turns morning huddles into a reliable engine for production and patient outcomes. Founded by practicing dentist Dr. Vinni K. Singh in Sunnyvale, California, DentScribe helps dentists reclaim time, deliver better care, and grow their practices without changing how they work. Learn more or book a demo at DentScribe.ai.

DMG Introduces New Clinical Protocols for Icon Resin Infiltration

2026-04-16T13:30:00.005-04:00

Dental professionals across North America now have access to updated clinical protocols for micro-invasive Icon resin infiltration. These new protocols from DMG incorporate enhanced diagnostic techniques, optimized infiltration timing, and structured treatment guidance designed to improve predictability and outcomes for patients with early enamel lesions and opacities.

The updated approach is the result of DMG’s commitment to clinical research and integrates transillumination-based diagnosis, extended infiltration times, and new pre-treatment strategies, alongside a newly-developed clinical decision tree that helps guide dental professionals through case selection and treatment pathways.

Resin infiltration represents a cornerstone of modern minimally invasive dentistry, enabling clinicians to intervene early and preserve healthy tooth structure while addressing patients’ esthetic concerns.

With the addition of improved diagnostics, refined protocols, and structured clinical guidance, the updated Icon approach aims to help dental professionals achieve more predictable, conservative, and esthetic treatment outcomes.

Enhanced Diagnostic Protocol: Transillumination

One of the most significant updates to the clinical workflow is the incorporation of transillumination as a diagnostic and monitoring tool that improves case selection and reduces the risk of misdiagnosis or unnecessary invasive treatment. It is also helpful during treatment to assess lesion dehydration and infiltration progress.

This diagnostic enhancement allows practitioners to better differentiate:

White spot enamel lesions and opacities
Early carious lesions
Developmental defects such as fluorosis

Optimized Infiltration Protocols

The updated protocol also emphasizes longer infiltration times, allowing deeper penetration of the low-viscosity resin into porous enamel.

“Over the years, I’ve found that success with Icon resin infiltration isn’t just about the material— it’s about refining the protocol,” said Dr. David Rice, a recognized dental industry key opinion leader and founder of igniteDDS. “By incorporating transillumination for better diagnosis and allowing more time for resin penetration, we’re seeing more predictable outcomes and significantly improved esthetic results. It’s a meaningful step forward in how we manage white spot lesions without drilling.”

Longer infiltration periods can improve diffusion of the resin intohypomineralizedenamel structures, increasing the masking effect and enhancing lesion stabilization.

Expanded Pre-Treatment Strategies

The new protocols also incorporate pre-treatment methods designed to produce predictable, esthetic outcomes, including:

Microabrasion to remove resistant enamel layers and improve access to the lesion body
Pre-whitening or bleaching protocols in certain cases to reduce contrast between affectedand healthy enamel prior to infiltration

Introducing the Icon Clinical Decision Tree

To support clinicians in implementing these updated protocols, a new Icon Clinical Decision Tree has been introduced.The decision tree provides a structured pathway to help dental professionals:

Evaluate lesion etiology and severity
Determine whether infiltration is appropriate
Identify when additional pre-treatment steps may be necessary
Select the correct treatment protocol based on lesion characteristics

The tool simplifies clinical decision-making and promotes predictable treatment planning for whitespot lesions, fluorosis, and early caries lesions.

Clinicians can access the decision tree here: https://drilling-no-thanks.info/wp-content/uploads/2026/02/DMGA_Icon_Decision-Tree_2026.pdf

About Icon Resin Infiltration

Icon is a micro-invasive treatment designed to halt early enamel caries and improve the appearance of white spot lesions without drilling. By infiltrating a low-viscosity resin into the lesion body, the technique arrests lesion progression and restores the natural optical properties of enamel.

About DMG

DMG manufactures and distributes a full range of market-leading dental materials and equipment that are internationally recognized for their quality and innovation. Known for its breakthrough dental technology—including flagship products like Luxatemp and LuxaCore Z Dual, the revolutionary Icon caries infiltrant, LuxaCrown long-term crown and bridge material, and new additions such as Ecosite restorative composites, and DentaMile 3D printing solution, complete with software, hardware and resins—DMG is committed to helping provide holistic solutions and streamlined workflows for dental and lab professionals to meet their needs through innovation, collaboration, and dedication.

For more information about DMG products, or to find a sales representative, please visit online at www.dmg-america.com, or call 800-662-6383.

PreatLoc Overdenture Attachments Integrate Seamlessly With Existing Workflows

2026-04-15T17:09:00.004-04:00

Backed by 45+ years of Preat expertise, PreatLoc overdenture attachments deliver reliable performance and long-lasting smiles. Compatible with the leading overdenture attachment system and supporting 18 implant systems across 35 connections, it integrates seamlessly into your existing workflow.

PreatLoc is engineered for compatibility with the leading overdenture attachment systems. Photo credit: Preat Corp.

Its tissue-friendly zirconium nitride (ZrN) coating helps reduce biofilm and inflammation, while retention inserts demonstrate dependable performance in 5,000-cycle internal testing. The tissue-friendly ZrN coating is designed for comfort and cleanliness, supporting long-term tissue health. Less biofilm and plaque adhesion reduce inflammation. The result is more comfort and happier, brighter smiles.

An anodized pink titanium denture cap enhances aesthetics in thin acrylics. Priced up to 33% less than leading systems, PreatLoc offers a cost-effective, high-performance solution for confident, predictable overdenture treatment.

In today’s market, practices and labs need solutions that deliver both reliability and value. PreatLoc raises the standard by delivering premium quality and exceptional customer service. For decades, Preat has helped clinicians and labs select the right components, streamline workflows, and achieve confident results. PreatLoc is engineered for compatibility with the leading overdenture attachment systems so you can integrate it seamlessly into your current workflow.

Other benefits of the attachment system include no new tooling required, no new color coding to learn, and the ability to immediately replace worn inserts and to easily restore new patients.

For more information, (800) 232-7732 or visit Preat.com/PreatLoc.

Dentsply Sirona Advances Implant Dentistry Summit

2026-04-14T13:04:00.004-04:00

Dentsply Sirona will welcome clinicians from around the world to Gothenburg, Sweden, on June 25–27 for the Implant Solutions World Summit 2026—a scientific gathering dedicated to advancing implant dentistry through evidence, collaboration, and innovation.

By combining scientific rigor with practical application, the Implant Solutions World Summit reinforces Dentsply Sirona’s commitment to supporting clinicians at every stage of implant therapy. Held in Gothenburg, widely recognized as the birthplace of modern implantology, the Implant Solutions World Summit 2026 reflects both the heritage and the future of implant dentistry.

43 International Speakers – 12 Scientific Sessions

Throughout the program, attendees will engage in sessions that transform ambition and scientific progress into practical insights, actionable strategies, and measurable clinical impact.

Among the key sessions in the 2026 scientific program are two forward-looking discussions addressing some of the most pressing questions in contemporary implant dentistry.

“The Immediacy Challenge – Balancing Technology, Esthetics and Biology” will explore the clinical considerations behind immediate implant protocols. While immediacy offers clear patient benefits, speakers will examine how these must be carefully weighed against long-term biological and restorative implications to ensure sustainable outcomes and patient quality of life. Chaired by Lyndon Cooper (US), the session features Stijn Vervaeke (BE), Martin Wanendeya (UK), and Christian Mertens (DE), who will share clinical data, case experiences, and decision-making strategies for predictable immediacy protocols.

In the session, “Connecting the Dots – Driving Efficiency and Enhancing Predictability for Clinical Success,” the focus shifts to digital integration and connected workflows. The discussion will address how digital planning, integrated solutions, and coordinated treatment pathways can increase efficiency while expanding access to implant therapy. Chaired by Martin Wanendeya (UK), the session includes contributions from Serhat Aslan (TR), Mischa Krebs (DE), Varisha Parikh (US), Mark Ludlow (US), and Steve Campbell (UK), who will demonstrate how digital connectivity transforms both clinical execution and the overall patient journey.

Together, these sessions reflect the overarching theme: aligning scientific evidence, clinical precision, and digital innovation to support practice growth while improving operational efficiency.

Seven Dedicated Masterclasses: Advanced Clinical Immersion

A defining feature of the Implant Solutions World Summit 2026 is its series of in-depth Masterclasses, designed as focused pre-congress sessions combining lecture, live demonstration, and hands-on training.

These Masterclasses provide concentrated clinical immersion in key areas of implant therapy such as peri-implant disease management, regenerative bone augmentation, patient-specific prosthetic solutions, full-arch rehabilitation, guided surgery, and fully digital treatment workflows. Designed to bridge scientific evidence with hands-on application, the sessions enable clinicians to deepen their expertise, refine surgical and restorative protocols, and enhance predictability across the complete implant treatment pathway—from diagnosis and planning to long-term maintenance.

More information and to register for the Masterclasses, visit: Masterclasses – Implant Solutions World Summit 2026

Comprehensive Solutions for Modern Implant Dentistry

The Implant Solutions World Summit will present Dentsply Sirona’s complete implant portfolio in the context of practical clinical application: implant systems, prosthetic and regenerative solutions, digital treatment planning tools, and DS Core integration. By showcasing the full workflow from diagnosis through prosthetic restoration and long-term maintenance, the event aims to provide clinicians with actionable insights that can be directly applied in daily practice.

“Implant dentistry is moving rapidly toward integrated workflows and evidence-driven solutions,” said Xavier Carro, Senior VP EMEA RCO & Global Lead for Henry Schein. “The Implant Solutions World Summit 2026 brings science and solutions together, offering clinicians not only a deeper understanding of our portfolio but also tangible strategies for more predictable outcomes.”

Register Now

Registration for the Implant Solutions World Summit 2026 is now open. Clinicians across Europe and beyond are invited to participate in this comprehensive, science-led exploration of implant dentistry’s current state and future direction.

For more information, visit www.dentsplysirona.com/worldsummit

About Dentsply Sirona

Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering, including dental and oral health products as well as other consumable medical devices, under a strong portfolio of world-class brands.

Dentsply Sirona’s innovative products provide high-quality, effective, and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The company’s shares are listed in the United States on Nasdaq under the symbol XRAY.

Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

American Association of Endodontists Releases Updated Guidelines for the Treatment of Traumatic Dental Injuries

2026-04-14T11:47:00.002-04:00

Updated guidelines appear online in the April 2026 Articles in Press of the Journal of Endodontics.

The American Association of Endodontists (AAE) has released its updated Recommended Guidelines for the Treatment of Traumatic Dental Injuries, providing clinicians with the latest evidence-based recommendations to support timely, accurate care following dental trauma. The guidelines were published in April 2026 onjendodon.com.

Designed to aid practitioners in evaluating and managing traumatic dental injuries, the updated guidelines emphasize that prompt diagnosis and treatment can significantly improve the chances of saving injured teeth.

“Dental trauma can happen at any time—from sports injuries to everyday accidents at home. How quickly and appropriately a tooth is treated can make all the difference,” said AAE President Dr. Steven J. Katz. “These updated guidelines provide dental professionals with clear, practical direction to help maximize successful outcomes for their patients.”

What’s New and Important

The updated AAE trauma guidelines:

Reflect current best practices and clinical evidence in the management of traumatic dental injuries
Provide structured guidance across a wide range of injury types, including fractures, luxation injuries and avulsed teeth
Include comprehensive follow-up protocols, recognizing that ongoing monitoring is critical to long-term success
Reinforce the importance of clinical judgment, acknowledging that treatment decisions must be tailored to each patient
Emphasize the appropriate use of imaging—including the role of 3D CBCT when indicated—to enhance diagnosis and support informed clinical decision-making

The guidelines are intended as a clinical resource—not rigid protocols—allowing endodontists to adapt recommendations based on individual patient needs, health status and circumstances.

Built on Global Collaboration

In developing the updated guidelines, the AAE incorporated foundational elements from the International Association of Dental Traumatology (IADT) 2020 Guidelines, ensuring alignment with globally recognized standards while tailoring recommendations for endodontic practice.

Why It Matters for Patients

Traumatic dental injuries are often unpredictable, but outcomes can be significantly improved with proper care.

While no treatment can guarantee long-term retention of a traumatized tooth, the AAE emphasizes that timely intervention using recommended procedures can greatly increase the likelihood of success—helping patients preserve their natural teeth whenever possible.

Access the Guidelines

The full Recommended Guidelines for the Treatment of Traumatic Dental Injuries are now available here.

About the American Association of Endodontists

The American Association of Endodontists (AAE) is dedicated to the excellence in the art and science of endodontics and to the highest standard of patient care. Endodontists are specialists in saving teeth, trained to diagnose and treat tooth pain and perform root canal treatment and other procedures relating to the interior of the tooth.

CephX Announces FDA Clearance for 3D Imaging and Expands Global AI Imaging Ecosystem with Integrations into DEXIS and Greyfinch

2026-04-13T10:30:00.005-04:00

With this additional regulatory approval, CephX becomes the only orthodontic AI diagnostic support company with FDA clearance for both 2D and 3D imaging.

Orca FDA 3D Logo

Alongside this regulatory milestone, Orca Dental AI also announced expanded strategic integrations with DEXIS™ and Greyfinch, further embedding CephX's AI-driven cephalometric analysis into leading imaging and practice management ecosystems worldwide.

Together, these developments strengthen CephX's position as a connected AI diagnostic platform designed to support orthodontists and dental specialists with faster analysis, improved visualization, and more efficient clinical workflows.

CEPHX Receives FDA Clearance for 3D Imaging

Orca Dental AI also announced that CEPHX3D has received FDA clearance (class II 510k), enabling clinicians to leverage advanced AI-powered 3D analysis within orthodontic imaging workflows.

CEPHX3D includes:

AI CBCT segmentation of the mandible, maxilla, full dentition (crowns and roots), and the inferior alveolar nerve (IAN)
An interactive web-based 3D STL & DICOM viewer allowing better visualization and understanding of patient anatomy, including the airway and maxillofacial structures, for clinical and educational purposes.

• Linear, angular, and volumetric measurement tools for anatomical analysis

- Maxillofacial Visualization
- Advanced Image Reporting & Insights
- CBCT Cross-Section Reports

This clearance further strengthens CephX's ability to deliver intelligent, AI-driven diagnostic tools that support clinicians with deeper insight into patient anatomy, anomalies and treatment planning.

Building the Connected AI Diagnostic Ecosystem

With integrations spanning imaging leaders like DEXIS and practice management platforms like Greyfinch, CephX continues to expand as a fully embedded AI engine across the orthodontic diagnostic journey.

"Our mission has always been to bring AI exactly where clinicians work — without adding friction," said Daniel Abraham, CEO & Founder of Orca Dental AI. "By integrating CephX into both imaging and practice management platforms, we're creating a connected ecosystem that saves time, improves accuracy, and empowers clinicians to focus on patient care."

Trusted by thousands of orthodontists and DSOs across more than 180 countries, CephX's FDA-cleared, HIPAA-compliant SaaS platform delivers automated cephalometric analysis, advanced 3D tools for CBCT imaging, and predictive diagnostic insights powered by a proprietary, extensive and diverse dataset

As digital dentistry continues to evolve, CephX remains committed to enabling scalable, intelligent workflows that improve clinical outcomes and operational efficiency worldwide.

CephX Now Integrated into DTX Studio™ Clinic by DEXIS

Through its integration with DTX Studio™ Clinic by DEXIS, CephX delivers AI-powered cephalometric analysis directly within the imaging workflow. Clinicians can generate automated tracings and analyses within seconds, accelerating treatment planning while maintaining clinical precision.

Key benefits include:

AI-driven cephalometric tracing and superimpositions
VTO/STO planning support
Immediate reporting and reduced turnaround time
Secure, cloud-based record management
Scalable deployment for multi-location practices and DSOs
Enhanced patient communication through clear visual analyses

This collaboration advances the DEXIS platform strategy and establishes CephX as the core AI intelligence layer powering modern orthodontic imaging.

"The integration of CephX and DTX Studio Clinic reinforces our commitment to delivering connected, AI-powered workflows that elevate diagnostic precision and clinical efficiency," said Robert Befidi, President of DEXIS. "By embedding advanced cephalometric automation directly into our platform, we are empowering orthodontic providers with faster insights and greater consistency across every clinic."

CephX Embedded into Greyfinch Cloud-Based Practice Management

CephX is now fully integrated into Greyfinch's cloud-based orthodontic practice management platform, bringing AI-powered diagnostic automation directly into the clinical and operational workflow.

Within Greyfinch, clinicians can upload 2D cephalometric images or 3D CBCT scans and receive complete AI-generated cephalometric analyses within seconds.

CephX automatically:

Converts 3D DICOM files into calibrated 2D radiographs
Identifies and validates anatomical landmarks
Generates ready-to-use cephalometric analyses
Streamlines diagnostic documentation within the patient record

Beyond cephalometric analysis, CephX also enables advanced AI-powered 3D diagnostic tools, including:

Automated CBCT and IOS segmentation into clean 3D STL models
IOS stitching and meshing to visualize crown and root anatomy
Smart Roots technology for AI-generated root movement visualization
A web-based DICOM/STL viewer with measurement, annotation, and collaboration tools
Airway visualization and analysis with volume and cross-sectional views
Additional AI-powered diagnostics including cross-section reports, nerve alerts, crossbite analysis, bone anchorage reports, and panoramic image generation

Together, these capabilities streamline radiographic workflows, reduce operational strain, and improve diagnostic consistency across single clinics and multi-location dental organizations.

"Our goal at Greyfinch is to simplify the operational and clinical workflow for orthodontic practices," said Jake Gulick, President of Greyfinch. "Integrating CephX allows our users to access advanced AI-powered cephalometric analysis without leaving the platform, saving time and improving the efficiency of treatment planning."

About Orca Dental AI (CephX)

Orca Dental AI is a global leader in AI-powered dental diagnostics and treatment planning. Founded in 2015, Orca transformed orthodontic care through CephX.com - one of the first platforms to automate imaging workflows and cephalometric analysis using machine learning.

Its FDA-cleared, cloud-based platform integrates seamlessly with leading imaging and practice management systems, delivering high-accuracy diagnostic support across orthodontics and broader dental care.

Learn more at:
www.cephx.com

PDS Health Expands Epic Into Academic Settings

2026-04-10T13:02:00.005-04:00

First-of-its-kind academic deployment across medical, dental, and ambulatory surgical settings advances dental-medical integration and revenue cycle performance.

University of the Pacific and PDS Health Technologies are partnering to build a more integrated foundation for clinical education, patient care and operations across medical, dental and ambulatory surgical settings.

PDS Health Technologies announced today a formal partnership with University of the Pacific (Pacific) to implement its dental-optimized instance of Epic, the nation’s preeminent electronic health record (EHR) system, across the Arthur A. Dugoni School of Dentistry and Pacific Health Care Collaborative. This collaboration marks a milestone in health sciences education: Pacific will become the first dental school in the nation to implement PDS Health Technologies’ specialized platform across dental, medical, and a future ambulatory surgical center, creating a more integrated model for clinical education and care.

PDS Health Technologies will deliver a unified platform across Pacific’s San Francisco and Sacramento campuses, bringing multiple care settings onto the same patient record. The result is a more integrated environment for patients, students, and clinicians, with stronger visibility across care settings and a more complete view of health information.

“This partnership reflects a shared belief that oral health must be more meaningfully integrated with overall health,” said Preston Raulerson, president of PDS Health Technologies. “By bringing medical, dental, and future surgical care settings onto the same patient record, University of the Pacific is advancing dental-medical integration in a way that strengthens both education and patient care. We are proud to support that vision with a proven instance of Epic optimized for dentistry and backed by real-world clinical and operational performance.”

Dr. Elisa Chávez, interim dean at the Arthur A. Dugoni School of Dentistry, said, “Integrating PDS Health Technologies’ instance of Epic into our clinical and academic environments across three distinct care settings is a transformative step. This implementation allows our students to practice true interdisciplinary care and prepares our graduates for a future where oral health is recognized as an indispensable component of primary care.”

At the Arthur A. Dugoni School of Dentistry, the platform will help extend classroom instruction into the clinical setting in a more meaningful way. With access to more complete patient information and real-time interoperability, students and faculty will be better positioned to support interdisciplinary collaboration, strengthen referral coordination, and apply the principles of dental-medical integration in real clinical environments.

“This partnership allows us to modernize our clinical technology architecture around a single, interoperable EHR,” said Raybel Ramos, associate dean of information technology at the Arthur A. Dugoni School of Dentistry. “PDS Health Technologies’ dental-optimized Epic instance gives us the performance, security, and scalability needed to support complex academic and clinical workflows while ensuring that data flows seamlessly across care settings. It’s a critical step in building a future-ready digital ecosystem for our students and clinicians.”

This strategic collaboration also establishes a stronger model for academic health environments, where education, clinical care, and operations are aligned on a single foundation. Together, PDS Health Technologies and Pacific are building infrastructure that supports the current patient experience while laying the groundwork for future advancement in clinical research, data insights, and integrated care delivery.

In addition to the Epic implementation, PDS Health Technologies will provide its revenue cycle managed services to help align clinical and operational performance across Pacific’s care settings. This support is designed to strengthen operational workflows, improve financial performance, and help create a more integrated academic and clinical environment.

The PDS Health Technologies platform is distinguished by its superior clinical performance, revenue cycle alignment, and robust, real-time interoperability with comprehensive health records. Supporting over 14 million unique patients, it represents the most rigorously tested and widely adopted dental-optimized instance of Epic in the world. This high-performance infrastructure currently serves as the technological backbone for multiple academic institutions and multi-state healthcare organizations across more than 1,250 sites of care.

For more information, visit pdshealthtechnologies.com.

About PDS Health Technologies

PDS Health Technologies delivers scalable health technology, revenue cycle services, consulting, and operations management for dental and medical organizations advancing integrated, connected care. Its dental-optimized performance platform aligns workflows, interoperability, data analytics, and patient experience to unite care teams, streamline documentation, and strengthen operational and financial performance. In addition to its performance platform and revenue cycle management services, the business provides staffing and advisory services to help partners optimize their technology, elevate patient and provider experience, and improve overall performance. For more information, visit pdshealthtechnologies.com.

About University of the Pacific

Founded in 1851, Pacific is California’s first and oldest university. The Northern California school, with nearly 7,000 students in more than 130 academic programs across campuses in Stockton, Sacramento, and San Francisco, is ranked in the Top 100 of American colleges and universities by The Wall Street Journal.

The hallmark of a Pacific education is immersive learning, one-on-one relationships with faculty and advisors, and experiential learning opportunities on and off its campuses. Pacific ranks No. 36 in social mobility nationally and is in the Top 2% in career earnings. Pacific also is the nation’s top private university designated by the U.S. Department of Education as both a Hispanic-Serving Institution and Asian American and Native American Pacific Islander-Serving Institution. It is ranked No. 4 for “Best Value” among all California schools. Learn more at pacific.edu.

About PDS Health

PDS Health continues the journey started by Pacific Dental Services in 1994, with a vision to redefine healthcare through the integration of dental and medical services. Its approach, centered on the connection between oral health and overall health, aims to create healthier, happier patients and set new benchmarks in the healthcare industry. As a leading provider of integrated healthcare support, the company delivers a broad spectrum of services to dental, dental specialties, and medical providers, enhancing operations and care delivery for clinicians across the U.S.

For more information about PDS Health and its vision, visit pdshealth.com.

Epic® is a registered trademark of Epic Systems Corporation.